Related Experiment Videos
Cardiovascular disease and sleep apnea
1Toronto Hospital (General Division), Ontario, Canada.
Current Opinion in Pulmonary Medicine
|November 1, 1995
Summary
Obstructive sleep apnea is linked to hypertension and heart issues. Treating sleep apnea with CPAP can improve cardiovascular outcomes in heart failure patients.
Area of Science:
- Cardiology
- Sleep Medicine
- Pulmonology
Background:
- Recent observations highlight the significant interaction between sleep apnea and cardiovascular function.
- Obstructive sleep apnea is increasingly recognized as an independent factor in developing hypertension and nocturnal myocardial ischemia.
Purpose of the Study:
- To review recent advances in understanding the cardiovascular implications of sleep-disordered breathing.
- To explore the impact of treating sleep apnea on cardiovascular outcomes, particularly in heart failure patients.
Main Methods:
- Review of recent scientific literature and clinical observations.
- Analysis of evidence linking sleep-disordered breathing to hemodynamic function and heart failure.
- Evaluation of treatment outcomes for nasal continuous positive airway pressure (CPAP) in selected patients.
Main Results:
- New evidence supports obstructive sleep apnea as an independent cause of hypertension and myocardial ischemia.
- Improved understanding of the acute effects of sleep-disordered breathing on hemodynamics.
- Strong evidence indicates that CPAP therapy improves cardiovascular outcome markers in heart failure patients with sleep apnea.
Conclusions:
- Sleep apnea significantly impacts cardiovascular health, contributing to hypertension and ischemia.
- Nasal CPAP therapy offers a promising strategy for improving cardiovascular outcomes in patients with coexisting sleep apnea and heart failure.
- These findings support the development of integrated diagnostic and treatment approaches for patients with sleep apnea and cardiovascular disease.